We are live on ! Find out more
TCM

Tang Capital Management Portfolio holdings

AUM $2.2B
1-Year Est. Return 156.35%
This Fund
S&P 500
This Quarter Est. Return
-12.17%
1 Year Est. Return
+156.35%
3 Year Est. Return
+492.92%
5 Year Est. Return
+804.3%
10 Year Est. Return
+3,997.35%
AUM
$612M
AUM Growth
-$176M
Cap. Flow
-$72.2M
Cap. Flow %
-11.79%
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
1
Reduced
1
Closed
–

Top Buys

Rank Stock Value
1
ODT
Odonate Therapeutics, Inc. Common Stock
ODT
+$28.2M

Top Sells

Rank Stock Value
1
HRTX icon
Heron Therapeutics
HRTX
+$100M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
ODT
1
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
$268M 43.72%
13,796,747
+1,384,409
+11% +$28.2M
HRTX icon
2
Heron Therapeutics
HRTX
$60.3M
$188M 30.75%
5,950,826
-2,696,572
-31% -$100M
LJPC
3
DELISTED
La Jolla Pharmaceutical Company
LJPC
$83.3M 13.6%
4,138,893
– –
RCKT icon
4
Rocket Pharmaceuticals
RCKT
$382M
$73M 11.92%
2,965,485
– –

Similar funds

LI
Leeward Investments Boston, Massachusetts $2.2B AUM 46.08% 1-Year Est. Return
MIHAS
Maj Invest Holding A/S Copenhagen K, Denmark $2.2B AUM 25.64% 1-Year Est. Return
1SB
1ST Source Bank South Bend, Indiana $2.21B AUM 28.75% 1-Year Est. Return
BOI
Bank of Italy Rome, Italy $2.2B AUM 1.53% 1-Year Est. Return
IHL
Investment House LLC Redondo Beach, California $2.21B AUM 39.6% 1-Year Est. Return
PCM
Parsons Capital Management Providence, Rhode Island $2.21B AUM 28.12% 1-Year Est. Return
BCP
BSN Capital Partners London, United Kingdom $2.21B AUM 22.85% 1-Year Est. Return
AAA
Affinity Asset Advisors New York $2.21B AUM 431.26% 1-Year Est. Return

Tang Capital Management's Q3 2018 Portfolio in Review

As of Q3 2018, Tang Capital Management held 4 positions worth $612M, down 22% from $789M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

Tang Capital Management withdrew a net $72.2M in Q3 2018, reducing 1 holding. Its largest reduction was Heron Therapeutics, cutting an estimated $100M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

Against the trend, Tang Capital Management added an estimated $28.2M to Odonate Therapeutics, Inc. Common Stock.

  • Tang Capital Management added most to Odonate Therapeutics, Inc. Common Stock in Q3 2018, an estimated $28.2M increase.
  • Tang Capital Management's biggest Q3 2018 reduction was Heron Therapeutics, cutting an estimated $100M.
  • Tang Capital Management's ten largest holdings make up 100% of its $612M portfolio in Q3 2018.
  • Tang Capital Management opened 0 new positions and closed 0 in Q3 2018.
  • Tang Capital Management's portfolio value fell 22% quarter-over-quarter to $612M.

Based on Tang Capital Management's 13F filing for Q3 2018, filed 14 Nov 2018.